TORONTO, ONTARIO--(Marketwire - July 23, 2012) - Trimel Pharmaceuticals Corporation (TSX:TRL) ("the "Company" or "Trimel") today announced the completion of enrolment and randomization of 304 patients in the Phase III clinical trial evaluating ...

Tuesday, 24 July 2012. Trimel Pharmaceuticals Corporation (TSX:TRL) ("the "Company" or "Trimel") today announced the completion of enrolment and randomization of 304 patients in the Phase III clinical trial evaluating CompleoTRT� in patients with male ...

SX Poised For Lower Open; Nexen May Jump On Deal - Canadian Commentary. (RTTNews.com) - Canadian stocks may open lower Monday as risk appetite waned on concerns over the euro zone financial situation after Spanish 10-year bond yields surged ...

7/23/2012 7:35 AM ET (RTTNews) - Trimel Pharmaceuticals Corp. (TRL.TO: News ) announced the completion of enrolment and randomization of 304 patients in the Phase III clinical trial evaluating CompleoTRT in patients with male hypogonadism or more ...

TORONTO, ONTARIO, Jul 18, 2012 (MARKETWIRE via COMTEX) -- Trimel Pharmaceuticals Corporation (TOR:CA:TRL) (the "Corporation") is pleased to announce that the Corporation and its subsidiaries have entered into a loan and security agreement with ...

TORONTO, ONTARIO--(Marketwire - July 17, 2012) -. NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.